281 related articles for article (PubMed ID: 28695294)
1. The role of MHC genes in contagious cancer: the story of Tasmanian devils.
Caldwell A; Siddle HV
Immunogenetics; 2017 Aug; 69(8-9):537-545. PubMed ID: 28695294
[TBL] [Abstract][Full Text] [Related]
2. Devil Facial Tumours: Towards a Vaccine.
Owen RS; Siddle HV
Immunol Invest; 2019 Oct; 48(7):719-736. PubMed ID: 31161832
[TBL] [Abstract][Full Text] [Related]
3. A second transmissible cancer in Tasmanian devils.
Pye RJ; Pemberton D; Tovar C; Tubio JM; Dun KA; Fox S; Darby J; Hayes D; Knowles GW; Kreiss A; Siddle HV; Swift K; Lyons AB; Murchison EP; Woods GM
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):374-9. PubMed ID: 26711993
[TBL] [Abstract][Full Text] [Related]
4. The newly-arisen Devil facial tumour disease 2 (DFT2) reveals a mechanism for the emergence of a contagious cancer.
Caldwell A; Coleby R; Tovar C; Stammnitz MR; Kwon YM; Owen RS; Tringides M; Murchison EP; Skjødt K; Thomas GJ; Kaufman J; Elliott T; Woods GM; Siddle HV
Elife; 2018 Aug; 7():. PubMed ID: 30103855
[TBL] [Abstract][Full Text] [Related]
5. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
Patchett AL; Flies AS; Lyons AB; Woods GM
Cell Mol Life Sci; 2020 Jul; 77(13):2507-2525. PubMed ID: 31900624
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal plasticity of devil facial tumour cells during in vivo vaccine and immunotherapy trials.
Patchett AL; Tovar C; Blackburn NB; Woods GM; Lyons AB
Immunol Cell Biol; 2021 Aug; 99(7):711-723. PubMed ID: 33667023
[TBL] [Abstract][Full Text] [Related]
7. The immunopeptidomes of two transmissible cancers and their host have a common, dominant peptide motif.
Gastaldello A; Ramarathinam SH; Bailey A; Owen R; Turner S; Kontouli N; Elliott T; Skipp P; Purcell AW; Siddle HV
Immunology; 2021 Jun; 163(2):169-184. PubMed ID: 33460454
[TBL] [Abstract][Full Text] [Related]
8. Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer.
Peel E; Belov K
Mamm Genome; 2018 Dec; 29(11-12):731-738. PubMed ID: 30225648
[TBL] [Abstract][Full Text] [Related]
9. Allorecognition in the Tasmanian devil (Sarcophilus harrisii), an endangered marsupial species with limited genetic diversity.
Kreiss A; Cheng Y; Kimble F; Wells B; Donovan S; Belov K; Woods GM
PLoS One; 2011; 6(7):e22402. PubMed ID: 21811598
[TBL] [Abstract][Full Text] [Related]
10. Inducible IFN-γ Expression for MHC-I Upregulation in Devil Facial Tumor Cells.
Ong CEB; Lyons AB; Woods GM; Flies AS
Front Immunol; 2018; 9():3117. PubMed ID: 30692995
[TBL] [Abstract][Full Text] [Related]
11. A human adenovirus encoding IFN-γ can transduce Tasmanian devil facial tumour cells and upregulate MHC-I.
Kayigwe AN; M Darby J; Lyons AB; L Patchett A; Lisowski L; Liu GS; S Flies A
J Gen Virol; 2022 Nov; 103(11):. PubMed ID: 36382885
[TBL] [Abstract][Full Text] [Related]
12. Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseases.
Kwon YM; Stammnitz MR; Wang J; Swift K; Knowles GW; Pye RJ; Kreiss A; Peck S; Fox S; Pemberton D; Jones ME; Hamede R; Murchison EP
R Soc Open Sci; 2018 Oct; 5(10):180870. PubMed ID: 30473836
[TBL] [Abstract][Full Text] [Related]
13. Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii).
Patchett AL; Coorens THH; Darby J; Wilson R; McKay MJ; Kamath KS; Rubin A; Wakefield M; Mcintosh L; Mangiola S; Pye RJ; Flies AS; Corcoran LM; Lyons AB; Woods GM; Murchison EP; Papenfuss AT; Tovar C
Cell Mol Life Sci; 2020 May; 77(9):1847-1858. PubMed ID: 31375869
[TBL] [Abstract][Full Text] [Related]
14. The differentiation state of the Schwann cell progenitor drives phenotypic variation between two contagious cancers.
Owen RS; Ramarathinam SH; Bailey A; Gastaldello A; Hussey K; Skipp PJ; Purcell AW; Siddle HV
PLoS Pathog; 2021 Nov; 17(11):e1010033. PubMed ID: 34780568
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
[TBL] [Abstract][Full Text] [Related]
16. Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours.
Ong CEB; Cheng Y; Siddle HV; Lyons AB; Woods GM; Flies AS
Open Biol; 2022 Oct; 12(10):220208. PubMed ID: 36259237
[TBL] [Abstract][Full Text] [Related]
17. Genomic insights into a contagious cancer in Tasmanian devils.
Grueber CE; Peel E; Gooley R; Belov K
Trends Genet; 2015 Sep; 31(9):528-35. PubMed ID: 26027792
[TBL] [Abstract][Full Text] [Related]
18. Cancer as a contagious disease.
Siddle HV
HLA; 2017 Apr; 89(4):209-214. PubMed ID: 28205368
[TBL] [Abstract][Full Text] [Related]
19. New insights into the role of MHC diversity in devil facial tumour disease.
Lane A; Cheng Y; Wright B; Hamede R; Levan L; Jones M; Ujvari B; Belov K
PLoS One; 2012; 7(6):e36955. PubMed ID: 22701561
[TBL] [Abstract][Full Text] [Related]
20. Contagious cancer: lessons from the devil and the dog.
Belov K
Bioessays; 2012 Apr; 34(4):285-92. PubMed ID: 22383221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
